Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Florence Mahé"'
Autor:
Anne-Laure Roux, Martin Rottman, Jean-Louis Gaillard, Simon Marmor, Julie Rogé, Olivier Sol, Jacques Ropers, Nicole Desplaces, Philippe Aegerter, Florence Mahé, Laurent Desire, Thomas W. Bauer, Beate Heym, Idir Ghout
Publikováno v:
Journal of Clinical Microbiology
We developed and evaluated a multiplex antibody detection-based immunoassay for the diagnosis of prosthetic joint infections (PJIs). Sixteen protein antigens from three Staphylococcus species ( Staphylococcus aureus , Staphylococcus epidermidis , and
Autor:
Bertrand Leblond, Anne-Sophie Casagrande, Florence Mahé, Laurent Desire, Matthew P. Pando, Thierry Besson, Emeline Throo, Florence Bachelot
Publikováno v:
Cancer Research. 74:2620-2620
The dual-specificity tyrosine phosphorylated and regulated kinase Mirk/DYRK1B belongs to an evolutionary conserved family of kinases involved in the control of growth and development. DYRK1B has low level of expression in most normal cell types but i
Publikováno v:
Cancer Research. 73:4147-4147
Alternative splicing of pre-mRNA, a key post-transcriptional mechanism allowing for the production of distinct proteins from a single gene, affects over 90% of human genes. Splicing plays a major role in gene regulation in normal tissues as well as i
Autor:
Laurent Desire, Emeline Throo, Diego Pallares, Vin Kotraiah, Florence Mahé, Anne-Sophie Casagrande, Matt Pando
Publikováno v:
Cancer Research. 72:1260-1260
Alternative splicing plays a major role in gene regulation, both in normal tissues as well as in disease. In cancer, abnormal alternative splicing, resulting in the production of novel transcript variants, has an impact on cellular processes related
Publikováno v:
Molecular Cancer Therapeutics. 10:B29-B29
Abnormal alternative splicing occurs in cancer, resulting in the production of novel transcript variants. Understanding the diverse mechanisms by which splicing dysregulation contributes to human disease will generate new perspectives for drug develo
Publikováno v:
Cancer Research. 71:4860-4860
Alternative RNA splicing is a key molecular mechanism for the generation of functional protein diversity. Abnormal alternative splicing can occur in cancer, resulting in the production of novel transcript variants. Therefore, development of platform